Comparison of several combinations maintenance and reliever therapy for asthma patients

Background: If asthma patients fail to achieve symptom control using a medium dose of inhaled corticosteroid (ICS) alone, addition of a long-acting β2 agonist (LABA) is the preferred treatment. Currently, there are several combinations of ICS/LABA that are available. Objective: Compare the effects...

Full description

Bibliographic Details
Main Author: Pablo Andrés Miranda-Machado
Format: Article
Language:English
Published: Colegio Mexicano de Inmunología Clínica y Alergia, A.C. 2018-06-01
Series:Revista Alergia México
Subjects:
Online Access:http://revistaalergia.mx/ojs/index.php/ram/article/view/423